Home Care Testing Market Size To Reach $18.30 Billion By 2030

Home Care Testing Market Growth & Trends

The global home care testing market size is expected to reach USD 18.30 billion by 2030, registering a CAGR of 9.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to factors, such as increasing demand for convenient and accessible healthcare solutions, growing focus on preventative healthcare and wellness, and technological advancements.An increase in technological advancements is another major factor contributing to the market growth. There have been significant advances in diagnostic technologies, such as digital imaging, molecular diagnostics, and lab-on-a-chip systems, which have enabled the development of innovative and effective at-home testing devices. In March 2023, Cue Health, a healthcare technology company, expanded its Cue Care platform with the launch of a suite of at-home diagnostic tests.

The tests are designed to provide individuals with quick and accurate results, allowing them to take control of their health and wellness. The new tests include a range of options, such as tests for COVID-19, influenza, and Respiratory Syncytial Virus (RSV).Furthermore, home care testing has helped to reduce healthcare costs. By enabling patients to conduct their own tests at home, healthcare providers can save on the cost of labor and infrastructure needed to perform testing in a healthcare setting. This can help make healthcare more affordable and accessible for patients, particularly those with chronic conditions requiring frequent testing. In addition, home care testing has increased accessibility for patients in rural or remote areas who may not have easy access to healthcare facilities.

By enabling patients to conduct tests at home, healthcare providers reach patients who might have difficulty accessing healthcare services.The pandemic has highlighted the importance of regular monitoring and early detection of diseases, which has boosted the demand for home care testing kits. Companies have been developing new technologies and solutions to address the growing demand for quick and accurate testing solutions. This has led to the development of a range of new home care testing products, including rapid antigen tests, antibody tests, and PCR tests, which have all been used to help diagnose and monitor COVID-19. In March 2023, Lucira Health received FDA authorization for its over-the-counter (OTC) flu and COVID-19 test. The test enables individuals to test themselves for COVID-19 and the flu at home, without the need for a healthcare provider.

 Request a free sample copy or view report summary: Home Care Testing Market Report

Home Care Testing Market Report Highlights

• Based on age, the geriatric segment captured the highest market share in 2022 due to the presence of the geriatric population coupled with a highincidence of chronic diseases

• Based on sample, the urine sample segment dominated the market in 2022. Advances in technology have led to more accurate and reliable urine sample testing, allowing for earlier detection and treatment of health conditions

• Based on test type, the infectious disease segment is expected to dominate the market in 2022. The growth of the segment is attributed to factors, such as increasing cases of infectious diseases globally and a high number of product approvals

• Based on distribution channel, the retail pharmacies segment is expected to dominate the market in 2022.These are easily accessible to consumers, with many located in convenient locations, such as shopping centers and grocery stores

• Based on product, the strip segment dominated the market in 2022. The strip tests are relatively inexpensive & easy to use and can be performed at home without the need for specialized equipment

• North America dominated the market and accounted for the largest revenue share of 32.40% in 2022 owing to the presence geriatric population and well-developed healthcare infrastructure

Home Care Testing Market Segmentation

Grand View Research has segmented the global home care testing market on the basis of age, sample, test type, distribution channels, product, and region:

Home Care Testing Age Outlook (Revenue, USD Million, 2018 - 2030)

• Pediatric

• Adult

• Geriatric

Home Care Testing Sample Outlook (Revenue, USD Million, 2018 - 2030)

• Urine

• Saliva

• Blood

• Others

Home Care Testing Test Type Outlook (Revenue, USD Million, 2018 - 2030)

• HIV Test Kit

• Diabetes and Glucose Tests

• Cholesterol and Triglycerides Tests

• Pregnancy Tests

• Infectious Diseases Tests

• Urinary Tract Infection Tests

• Others

Home Care Testing Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Retail Pharmacies

• Supermarket/Hypermarket

• Online Pharmacies

Home Care Testing Product Outlook (Revenue, USD Million, 2018 - 2030)

• Strip

• Cassette

• Test Panel

• Midstream

• Dip Card

• Others

Home Care Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Home Care Testing Market

• Abbott

• BD

• Quidel Corp.

• BioSure

• F. Hoffmann-La Roche Ltd.

• Nova Biomedical

• Siemens Healthcare GmbH

• ACON Laboratories, Inc.

• OraSure Technologies, Inc.

• Chembio Diagnostics, Inc.